ArticleFrontiers in oncology2021

The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study.

Dongxu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.